About this trial
The goal of this clinical trial is to learn if topical application on the all surface of 10% Povidone Iodine (Povi-One) in healthy participants in transitional or permanent dentition (10-17 y) prevents new white spot lesions in the maxillary anterior teeth at 1 year of follow-up.
Researchers will compare Povi-One to a placebo to see if Povi-One works to prevent new white spot lesions.
It will also learn about the safety of topical 10% Povidone Iodine.
The main questions it aims to answer are:
1. Does Povi-One prevent the development of any white spot lesion on the surface of maxillary anterior teeth? 2. Does Povi-One lower the probability of any International Caries Detection and Assessment System (ICDAS) score greater than 0 and mean modified Löe-Silness Gingival Index (GI) in the intervention group?
Researchers will
1. Score GI without cleaning participants teeth, then score ICDAS of maxillary and mandibular incisors after participants brush and floss their teeth and take a photograph of maxillary 6 anterior teeth 2. Apply Povi-one (or control) at the consultation appointment before placing fixed orthodontic appliances and 3, 6, and 9 months after appliance placement
Researchers will
1. Recall using Zoom 24-48 hours after the first application of Povi-One and examine the participant's mouth for oral lesions using a structured paper checklist 2. Interview the caregiver to complete a paper questionnaire on adverse effects
Researchers will
1. Score GI, and then score ICDAS of maxillary and mandibular incisors in 6, 12 months after appliance placement 2. Evaluate the development of white spot lesions on maxillary central and lateral incisors in 6, and 12 months after appliance placement
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Healthy children and teens (10-17 years old)
Transitional or permanent dentition of at least 4 permanent anterior teeth in each arch
Full fixed appliance orthodontic treatment is expected to last at least one year
Disqualifiers
Allergies to iodine
Chronic prophylactic use of antibiotics
Diagnosis of thyroid disease
Conditions that could impair routine oral hygiene procedures.
Trial design
Parallel
Treatments tested in this trial
Placebo
DrugPlacebo (Double distilled water matched in color and taste) will be applied topically by the graduate student to all tooth surfaces at the consultation appointment before the placement of fixed appliances and at 3, 6, and 9 months after appliance placement.
Povidone-iodine solution
DrugPovidone-iodine solution will be applied topically by the graduate student to all tooth surfaces at the consultation appointment before the placement of fixed appliances and at 3, 6, and 9 months after appliance placement.
Treatment groups
Trial outcomes
Primary outcomes
Photograph
6 maxillary anterior teeth (central incisors, lateral incisors, and canines) will be photographed with a clinical cam in a 10-degree tilted head position to reduce reflection without drying teeth. A new development of white spot lesion of the maxillary 4 anterior teeth using a photograph at a baseline (before the placement of fixed appliances). The images will be labeled with randomly assigned patient ID numbers and dates, and stored on a password-protected computer for later analysis. The orthodontic graduate students will be trained to label the photos, and then deliver them to the study coordinator. A trained and calibrated independent evaluator will assess whether there are new white spot lesions by comparing progress with the baseline photos taken before the placement of fixed appliances. The examiner will be blind to group assignments.
Secondary outcomes
Gingival index
The gingival index will be evaluated at the baseline (before the placement of the fixed appliances, 6 months, and 12 months after the placement) Scoring gingival index will be performed before the patient performs any oral hygiene procedures at the time of the visit. A modification of the Löe-Silness Gingival Index (GI) will be used, scoring the mid-labial aspect of the gingiva of each anterior tooth on a scale from 0 (normal gingiva); 1 (Mild inflammation: slight change in color and slight edema but no bleeding on probing); 2 (Moderate inflammation: redness, edema, and glazing, bleeding on probing); to 3 (severe inflammation: marked redness and edema, ulceration with tendency to spontaneous bleeding). Orthodontic graduate students will receive training and complete a calibration exercise for scoring the GI.
International Caries Detection and Assessment System (ICDAS)
After the gingival index has been completed, patients will be asked to brush and floss their teeth, and any residual plaque can be removed with a micro brush. ICDAS will be evaluated at the baseline (before the placement of the fixed appliances, 6 months, and 12 months after the placement). Regarding the ICDAS, only the anterior teeth will be assessed clinically by the graduate orthodontic student. No magnification will be used. The graduate student examiners will be trained and calibrated to establish inter-rater reliability on a sample of 10 patients with and without ICDAS pre-cavitated lesions by a trained gold standard examiner . (Minimum acceptable ICC=.7) A review for examiners will be held for 1 year.
Other outcomes
Visual analog scale (VAS)
After the first topical application in the clinic, the participant will complete a 100 mm VAS anchored with "not acceptable at all" to "completely acceptable." This assessment will be completed again at the three-month recall.
Safety measure (allergic reaction and adverse effect)
Participants will be recalled by the orthodontic graduate students using Zoom 24-48 hours after the first application and the participant's mouth will be examined for oral lesions using a structured paper checklist which will include the participant ID, date, and the name of the person completing the checklist. At the same appointment, the caregiver will be interviewed to complete a paper questionnaire on adverse effects. The orthodontic graduate students will interview the caregiver who is self-identified as the main adult responsible for the participants\' orthodontic care. Caregiver and participants will be given an emergency telephone number and asked to report significant abnormalities the participant experiences. The principal investigator will review and follow up. If the patient is having a severe medical emergency, they will be directed to contact their physician and/or go to the emergency room immediately.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.